"Reflecting on the Dutch Health Council's decision in 2018 to choose PPV23 for pneumococcal vaccination in older adults, our results on [vaccine effectiveness] against IPD align with the anticipated ...

In adults living with HIV, the 21-valent pneumococcal conjugate vaccine (PCV) V116 was well tolerated and effective against all 21 target serotypes. The immune responses were comparable to those ...

Merck (NYSE:MRK) announced late-stage trial data on Thursday suggesting that its Capvaxive vaccine, indicated for adults to prevent invasive pneumococcal disease and pneumonia, is also effective in ...

—Among adults, coverage and preventable burdens were lowest for pneumococcal conjugate vaccine (PCV) 15 and highest for PCV31, with PCV21 preventing notable burdens of both acute respiratory ...

A new vaccine for pneumococcal disease will be tested under an international trial aiming to provide greater protection to babies against the common infection that causes pneumonia, sinusitis and ...

HONG KONG, Jun 20, 2025 - (JCN Newswire) - - Pneumonia is a form of acute respiratory infection, that is common in all age groups and can cause mild to life-threatening illness. It is also the single ...

The Australian government announced last week there's a new vaccine for pneumococcal disease on the National Immunization Program for all children. Pneumococcus is also responsible for most ...

Streptococcus pneumoniae remains a leading cause of pneumonia, meningitis and sepsis worldwide, particularly among young children and older adults. Prevention hinges on vaccination with polysaccharide ...

Pharmac is proposing changes that would give more New Zealanders access to funded vaccines from 2027, including expanded access to the flu vaccine for young children. The proposal includes changing ...